Veterinary

dvm360® Announces First 2020 Fetch dvm360® Conference Virtual Experience

Wednesday, July 1, 2020 - 4:42pm

1 multimedia platform in the veterinary industry, announces that three of its live 2020 events will transition to a live virtual conference experience Aug. 26-31.

Key Points: 
  • 1 multimedia platform in the veterinary industry, announces that three of its live 2020 events will transition to a live virtual conference experience Aug. 26-31.
  • We are thrilled to combine our HospitalDesign360 and the Fetch dvm360 conferences in Kansas City and Baltimore into one large interactive platform, said Mike Hennessy Jr., president and CEO of MJH Life Sciences, parent company of dvm360.
  • The live virtual Fetch dvm360 Conference will offer a 360-degree educational experience with the clinical, management, technician and wellness continuing education (CE) needed to provide the best possible pet care.
  • These conferences include three Fetch dvm360 conferences and the Atlantic Coast Veterinary Conference, CE events that have been a staple in the veterinary community for 30 years.

PathogenX Launches PX2 Technology for Fast, Compliant Disposal of In-Facility Medical Waste

Tuesday, June 30, 2020 - 7:08pm

Carmel-based PathogenX , a medical device company which develops, manufactures, and distributes proprietary technology designed to dramatically simplify the process of medical waste disposal, today announced the official launch of its unique, double-batch, on-site sterilization device, the PX2 .

Key Points: 
  • Carmel-based PathogenX , a medical device company which develops, manufactures, and distributes proprietary technology designed to dramatically simplify the process of medical waste disposal, today announced the official launch of its unique, double-batch, on-site sterilization device, the PX2 .
  • Each PX2 device is capable of processing up to 10 gallons of medical waste per day.
  • Disposing of medical waste on-site with the PX2 is also considerably less expensive than haul-and-treat services and the company offers its customers financing and lease-to-own options so that the device pays for itself.
  • Note to media: photos of PX2 device and images of post-PX2d medical waste rendered harmless and fully sterilized, are available upon request.

Global Animal Disinfectant Market 2020-2024 | Evolving Opportunities with Diversey Inc. and Evans Vanodine International Plc | Technavio

Friday, June 26, 2020 - 11:30pm

The global animal disinfectant market is expected to grow by USD 2.00 million as per Technavio.

Key Points: 
  • The global animal disinfectant market is expected to grow by USD 2.00 million as per Technavio.
  • In addition, the growing focus on the development of sustainable animal disinfectants is anticipated to boost the growth of the animal disinfectant market.
  • These factors are fueling the growth of the global animal disinfectant market.
  • Global Animal Growth Enhancers Market Global animal growth enhancers market by product (antibiotics, prebiotics and probiotics, feed enzymes, and others) and geography (North America, APAC, Europe, South America, and MEA).

Zoetis to Host Webcast and Conference Call on Second Quarter 2020 Financial Results

Friday, June 26, 2020 - 1:30pm

(NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 6, 2020.

Key Points: 
  • (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 6, 2020.
  • Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn David will review second quarter 2020 financial results and respond to questions from financial analysts during the call.
  • Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations .
  • A replay of the webcast will be made available on Aug. 6, 2020.

Bayer announces agreements to resolve major legacy Monsanto litigation

Wednesday, June 24, 2020 - 5:50pm

Bayer announced today a series of agreements that will substantially resolve major outstanding Monsanto litigation, including U.S. Roundup product liability litigation, dicamba drift litigation and PCB water litigation.

Key Points: 
  • Bayer announced today a series of agreements that will substantially resolve major outstanding Monsanto litigation, including U.S. Roundup product liability litigation, dicamba drift litigation and PCB water litigation.
  • The decision to resolve the Roundup litigation enables us to focus fully on the critical supply of healthcare and food.
  • The Roundup agreements are designed as a constructive and reasonable resolution to a unique litigation, said Kenneth R. Feinberg, court-appointed mediator for the settlement talks.
  • Bayer also announced a series of agreements that resolve cases representing most of the companys exposure to PCB water litigation.

COVID-19: Significant Shift in Strategy of Animal Wound Care Market 2020-2024 | Increase in Pet Ownership to Augment Growth | Technavio

Tuesday, June 23, 2020 - 8:55pm

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • View the full release here: https://www.businesswire.com/news/home/20200623005725/en/
    Technavio has announced its latest market research report titled Global Animal Wound Care Market 2020-2024 (Graphic: Business Wire)
    Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied.
  • Increase in pet ownership has been instrumental in driving the growth of the market.
  • https://www.technavio.com/report/report/animal-wound-care-market-industr...
    Animal Wound Care Market 2020-2024: Segmentation
    Animal Wound Care Market is segmented as below:

Patterson Companies Declares Regular Quarterly Cash Dividend

Monday, June 22, 2020 - 11:34pm

The Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) today declared a quarterly cash dividend of $0.26 per share.

Key Points: 
  • The Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) today declared a quarterly cash dividend of $0.26 per share.
  • The dividend will be payable on, or about, July 31, 2020, to shareholders of record as of the close of business on July 17, 2020.
  • Patterson Companies Inc. (Nasdaq: PDCO) connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services and innovative business solutions that enable operational and professional success.
  • Our comprehensive portfolio, distribution network and supply chain are equaled only by our dedicated, knowledgeable people who deliver unrivaled expertise and unmatched customer service and support.

Mainstay Medical Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain

Monday, June 22, 2020 - 7:00am

Mainstay Medical Holdings plc (Mainstay or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved the Companys Premarket Approval (PMA) application for ReActiv8, its implantable neurostimulation system to treat intractable chronic low back pain.

Key Points: 
  • Mainstay Medical Holdings plc (Mainstay or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved the Companys Premarket Approval (PMA) application for ReActiv8, its implantable neurostimulation system to treat intractable chronic low back pain.
  • We are thrilled to receive FDA approval of ReActiv8, which is designed to be a restorative treatment and represents a new option for patients suffering with chronic low back pain.
  • I have seen ReActiv8 provide durable improvements in back pain, the disabling effects of back pain, and quality of life.
  • Mainstay Medical Holdings is a medical device company focused on commercializing an innovative implantable restorative neurostimulation system, ReActiv8, for people with disabling Chronic Low Back Pain (CLBP).

Assessment of COVID-19's Effect on Small Animal Imaging Market 2020-2024 | Rising Demand for Pet Insurance to Augment Growth | Technavio

Friday, June 19, 2020 - 8:00pm

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities.
  • Rising demand for pet insurance has been instrumental in driving the growth of the market.
  • https://www.technavio.com/report/report/small-animal-imaging-market-indu...
    Small Animal Imaging Market 2020-2024: Segmentation
    Small Animal Imaging Market is segmented as below: